Clinical Trial Update: XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates neoadjuvant therapy with XELOX plus bevacizumab followed by capecitabine plus bevacizumab with radiotherapy in locally advanced rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials | Conditions: Rectal Neoplasms, Locally Advanced Rectal Adenocarcinoma | Phase 2 | Status: UNKNOWN